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Histone modifications are thought to serve as epige-
netic markers that mediate dynamic changes in chroma-
tin structure and regulation of gene expression. As a
model system for understanding epigenetic silencing, X
chromosome inactivation has been previously linked to
a number of histone modifications including methyla-
tion and hypoacetylation. In this study, we provide evi-
dence that supports H2A ubiquitination as a novel epi-
genetic marker for the inactive X chromosome (Xi) and
links H2A ubiquitination to initiation of X inactivation.
We found that the H2A-K119 ubiquitin E3 ligase Ring1b,
a Polycomb group protein, is enriched on Xi in female
trophoblast stem (TS) cells as well as differentiating
embryonic stem (ES) cells. Consistent with Ring1b me-
diating H2A ubiquitination, ubiquitinated H2A (ubH2A)
is also enriched on the Xi of both TS and ES cells. We
demonstrate that the enrichment of Ring1b and ubH2A
on Xi is transient during TS and ES cell differentiation,
suggesting that the Ring1b and ubH2A are involved in
the initiation of both imprinted and random X inactiva-
tion. Furthermore, we showed that the association of
Ring1b and ubH2A with Xi is mitotically stable in non-
differentiated TS cells.
Dynamic changes in chromatin structure play important
roles in regulating DNA-templated processes such as transcrip-
tion. Regulation of chromatin dynamics can be achieved
through ATP-dependent chromatin remodeling and covalent
modifications of histones, such as acetylation, methylation,
phosphorylation, and ubiquitination (1–4). Studies in the past
several years have established a fundamental role for histone
acetylation and methylation in regulating gene activity (4–6).
However, the role of histone ubiquitination is just beginning to
be revealed (7).
Both histones H2A and H2B are subject to modification by
ubiquitin. The identification of E2 and E3 involved in H2B
ubiquitination (8–10) and the discovery of the “cross-talk” be-
tween histone methylation and ubiquitination (11, 12) have set
the stage for functional analysis of histone H2B ubiquitination.
Recent studies indicate that, unlike other reversible histone
modifications in which addition or removal of a group from a
histone molecule results in opposing transcriptional effects,
sequential ubiquitination and deubiquitination are both in-
volved in transcriptional activation (13, 14). Although histone
H2A was the first protein identified to be ubiquitinated (15), its
functional significance has been elusive until very recently
when we biochemically purified the H2A-K119 ubiquitin E3
ligase and linked its function to Polycomb silencing (16).
Dosage compensation in mammals is achieved by transcrip-
tional silencing of one of the two X chromosomes in female cells
(17). X inactivation occurs during early embryonic development
and is controlled by a large non-coding RNA, Xist (18, 19). After
coating the inactive X chromosome (Xi), Xist RNA is believed to
recruit silencing factors to mediate a series of epigenetic
changes to the chromosome. The epigenetic changes include
methylation and hypoacetylation of histones, incorporation of
macroH2A, and CpG methylation (20).
Genetic and biochemical studies have revealed that Poly-
comb group (PcG)1 proteins function in at least two distinct
protein complexes including the Eed-Ezh2 complex and the
PRC1 complex (21, 22). Previously, we as well as others (23–
25), have demonstrated that the Eed-Ezh2 complex and its
associated H3-K27 methyltransferase activity are recruited to
Xi and participate in X inactivation. However, no link between
components of the PRC1 complex and X inactivation has been
established. Our recent finding that H2A ubiquitination is
mediated by a Ring1b-containing PcG complex (16) prompted
us to investigate a potential role of H2A ubiquitination in X
inactivation. Our study revealed that both Ring1b and ubiq-
uitinated H2A (ubH2A) are specifically enriched on the Xi of
trophoblast stem (TS) cells as well as differentiating embryonic
stem (ES) cells. In addition, analysis of the dynamic nature of
the Xi enrichment suggests that Ring1b and ubH2A are likely
involved in the initiation stage of X inactivation. Taken to-
gether, our study reveals a new epigenetic feature of Xi and
suggests a role for Ring1b and ubH2A in the initiation stage of
X inactivation in both extraembryonic and embryonic cell
lineages.
EXPERIMENTAL PROCEDURES
Cell Culture and Differentiation—TS cells were kindly provided by
Gary Uy (26) and cultured as described (27). To induce TS cell differen-
tiation, human fibroblast growth factor-4 (Sigma), heparin (Sigma), and
embryonic mouse fibroblast-conditioned medium were removed from the
culture medium. The female mouse ES cell line 129/cas16, derived from a
female 129Sv/Jae-Castaneous hybrid blastocyst, was maintained and
differentiated following a previously described procedure (28).
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Immunostaining and Antibodies—For immunostaining, TS or ES
cells were plated onto 0.2% gelatin (Sigma)-coated glass coverslips or a
6-well plate and cultured for 1 or 2 days. After washing with PBS and
cold CSB buffer (0.1 M NaCl, 0.3 M sucrose, 3 mM MgCl2 in 10 mM
PIPES, pH 6.8), cells were permeabilized for 5 min with cold CSB buffer
containing 0.5% Triton X-100. The cells were then washed twice with
cold CSB buffer and fixed in 4% paraformaldehyde for 20 min. Fixed
cells were then washed three times with blocking buffer (1% bovine
serum albumin in PBS) and blocked for 30 min before incubating with
primary antibodies for 1 h in a humidified chamber. After three con-
secutive 5-min washes in blocking buffer, cells were incubated with
secondary antibodies for an additional hour. The cells were then
washed with PBS and stained with 4,6-diamidino-2-phenylindole dihy-
drochloride (DAPI) in PBS. Cells were washed again twice with PBS
and water and then mounted in fluorescent mounting medium (Dako).
Antibodies against Ezh2, H3–3mK27, Ring1b, and Ring1a have been
described previously (23, 29, 30). The anti-ubH2A antibody (E6C5),
described previously (31), and anti-Bmi1 antibody were purchased from
Upstate Biotechnology. Secondary antibodies for immunofluorescence
were from Jackson ImmunoResearch Laboratories.
RESULTS AND DISCUSSION
Ring1b and ubH2A Are Enriched on the Xi in Trophoblast
Stem Cells—Blastocyst-derived female TS cells belong to the
extraembryonic cell type (27). Since the paternal X chromo-
some is imprinted in TS cells, they provide one of the best in
vitro models for analyzing imprinted X inactivation (32). Pre-
vious studies have demonstrated that the Eed-Ezh2 Polycomb
complex and complex-mediated histone H3-K27 trimethylation
are enriched on the Xi in TS cells (23, 24, 33). Our recent
studies revealed that a Ring1b-containing PcG complex partic-
ipates in histone H2A ubiquitination and is functionally linked
to the Eed-Ezh2 complex in PcG silencing (16). To investigate
whether Ring1b-mediated H2A ubiquitination participates in
X inactivation in TS cells, we examined Ring1b and ubH2A
distribution in female TS cells by immunofluorescence stain-
ing. Toward this end, TS cells were double-labeled with a
monoclonal antibody E6C5 (31), which specifically recognizes
histone H2A ubiquitinated on lysine 119 (H2A-ubK119), to-
gether with a polyclonal antibody against histone H3 trimethy-
lated on lysine 27 (H3–3mK27), which marks the Xi (23). Re-
sults shown in Fig. 1 demonstrate a clear colocalization of
ubH2A with H3–3mK27 on Xi (top panels). Consistent with our
previous finding that Ring1b mediates H2A ubiquitination in
vitro and in vivo (16), we also observed colocalization of Ring1b
with ubH2A on Xi (bottom panels). In addition to Ring2, the
human counterpart of the mouse Ring1b, the ubiquitin ligase
complex purified from HeLa cells also include Ring1 (Ring1a),
Bmi1, and HPH2 (16). However, similar staining using antibod-
ies against Ring1a and Bmi1 did not reveal elevated levels of
either at the Xi despite their specific nuclear staining (supple-
mental Fig. S1). This result reflects that Ring1b has alternate
functional partners in different cell types. Collectively, the above
data demonstrate that ubH2A and the relevant ubiquitin ligase
Ring1b are enriched on the inactive X chromosome in TS cells.
Association of Ring1b and ubH2A with Xi in TS Cells Is
Mitotically Stable—Previous studies in TS cells indicate that
association of the Eed-Ezh2 complex with Xi is mitotically
stable (32), consistent with a role of the complex in the main-
tenance of imprinted X inactivation in trophectoderm cells (25).
To determine whether Ring1b and ubH2A are also stably as-
sociated with Xi during mitosis, we examined their staining
patterns throughout mitosis in TS cells. Costaining of anti-
ubH2A and anti-Ring1b antibodies was performed as above,
and cells at different stages of mitosis were identified by DAPI
staining. In parallel, co-staining of anti-H3–3mK27 and anti-
Ezh2 antibodies was also performed as a control. Data shown
in Fig. 2 indicate that both ubH2A and Ring1b antibodies
stained a distinct chromosome in prophase and metaphase TS
cells (top two rows). Interestingly, association of Ring1b protein
with Xi is retained on individual sister chromatids at both
anaphase and telophase, which colocalizes exactly with the
ubH2A signals (bottom two rows). Similar results were also
observed for the Eed-Ezh2 complex as well as for the H3–
3mK27 marker (supplemental Fig. S2). One possible explana-
tion of the result is that the Ring1b complex is retained through
its interaction with the Xist RNA, similar to the retention of the
Eed-Ezh2 complex (32). This result suggests that the Ring1b-
mediated H2A ubiquitination could play a role in maintenance
of X inactivation during the cell cycle.
Ring1b and ubH2A Dissociate from Xi during TS Cell Dif-
ferentiation—Shortly after implantation, trophoblast cells dif-
ferentiate into a number of extraembryonic cell types, includ-
ing trophoblast giant cells. TS cells can also be differentiated
into trophoblast giant cells in vitro after withdrawal of fibro-
blast growth factor-4 and heparin from the culture medium
(27). To investigate whether Ring1b and Ring1b-mediated H2A
ubiquitination participate in maintaining X inactivation in tro-
phoblast giant cells, we asked whether Ring1b and ubH2A are
present on the Xi in differentiated TS cells. After 2, 4, 8, and 12
days of differentiation, TS cells were costained with anti-
Ring1b and anti-ubH2A antibodies or anti-Ezh2 and anti-H3–
FIG. 1. Colocalization of Ring1b and ubH2A on the inactive X
chromosome in TS cells. Female TS cells were stained with anti-
ubH2A (red) and anti-H3–3mK27 (green), or anti-Ring1b (green) anti-
bodies as indicated. DNA is counterstained with DAPI.
FIG. 2. Ring1b and ubH2A remain on inactive X chromosome
throughout mitosis in TS cells. Female TS cells were double stained
with anti-Ring1b (green) and anti-ubH2A (red) antibodies at different
stages of mitosis, as indicated. Merged images demonstrate that Ring1b
and ubH2A colocalize and remain on Xi throughout the mitosis. DNA is
counterstained with DAPI (blue).
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3mK27 antibodies. The immunostaining results indicate a pro-
gressive loss of enrichment of both Ring1b and ubH2A on Xi
during TS cell differentiation (Fig. 3a). The Xi-enriched stain-
ing pattern for both Ring1b and ubH2A becomes diffused
throughout the entire nucleoplasm at 4 days of differentiation,
and most of the giant cells lost the Xi-enriched staining pattern
after 8 days of differentiation (Fig. 3a). Quantitative analysis
showed the dissociation of Ring1b and ubH2A from Xi occurs
after the loss of Eed-Ezh2 and before the loss of 3mK27 (Fig.
3b). Given that Xist RNA continues to coat the Xi in trophoblast
giant cells after 8 days of differentiation (23), these results
suggest that the Ring1b complex and ubH2A are not required
for the continued coating of Xi by Xist RNA, similar to that of
Ezh2 and H3–3mK27 (23). These results also suggest that
Ring1b and ubH2A may not be required for maintenance of
imprinted X inactivation in differentiated trophoblast giant
cells. Instead, they likely function during initiation of im-
printed X inactivation.
Enrichment of Ring1b and ubH2A on Xi during ES Cell
Differentiation Correlates with Initiation of X Inactivation—
ES cells are derived from the inner cell mass of blastocysts
where X chromosomes undergo random X inactivation (17).
Previous studies have established that X inactivation initiates
shortly after ES cells are induced to differentiate (20, 34). To
investigate a possible role for Ring1b-mediated H2A ubiquiti-
nation in random X inactivation, we performed immuno-
staining of mouse female ES cells during their differentiation
using the Ring1b and ubH2A antibodies. Previously, we and
others (23, 24) have shown that Ezh2-mediated H3-K27 tri-
methylation is transiently enriched on the Xi during ES cell
differentiation. Therefore, parallel stainings using anti-Ezh2
and anti-H3-3mK27 antibodies were also performed. Consist-
ent with the fact that X inactivation does not occur in undif-
ferentiated ES cells, no enrichment of either Ring1b or ubH2A
in Xi was detected (Fig. 4a). However, Ring1b and ubH2A start
to accumulate on Xi as soon as ES cells were induced to differ-
entiate. The percentage of cells with enriched Ring1b and
ubH2A on Xi reached as high as 60% after 3–4 days of differ-
entiation (Fig. 4, b–d), a result similar to that of two other PcG
proteins Ezh2 and Eed (23, 24). Like that of Ezh2 and H3–
3mK27, enrichment of Ring1b and ubH2A on Xi is transient as
progressive loss of the enrichment occurs after 4 days of differ-
entiation, and no enrichment was detected after 13 days of
differentiation (Fig. 4d). The asynchronous nature of ES cell
differentiation in culture likely accounts for the observation
that enrichment of Ring1b and ubH2A on Xi does not occur in
all cells at any given time point. Analysis of the association and
disassociation dynamics of Ezh2/H3–3mK27 and Ring1b/
ubH2A on Xi indicate that Ring1b/ubH2A appears to disasso-
ciate after Ezh2 but before H3–3mK27, although they have
similar dynamics in their binding to Xi (Fig. 4d). This result,
together with that shown in Fig. 3b, indicates that H3-K27
trimethylation is a relatively more stable marker than ubH2A.
In addition to Ring1b and ubH2A, we also performed parallel
immunostaining using the Ring1a and Bmi1 antibodies. Simi-
lar to our findings in TS cells (supplemental Fig. S1), neither
FIG. 3. Enrichment of Ring1b and ubH2A on Xi is transient
during female TS cell differentiation. a, immunostaining of Ring1b
(red) and ubH2A (green) in nuclei (blue) of female TS cells differentiated
for 2, 4, 8, and 12 days. The merged images demonstrate that Ring1b
and ubH2A colocalize and are enriched on the Xi in early, but not late,
stages of differentiation. b, quantification of the data presented in a and
parallel Ezh2/H3–3mK27 staining during TS cell differentiation. The
graphs depict the percentage of cells with Xi accumulation for Ezh2
(open circles), H3–3mK27 (solid circles), Ring1b (open squares), and
ubH2A (solid squares), respectively. More than 100 cells were counted
for each time point.
FIG. 4. Enrichment of Ring1b and ubH2A on Xi is transient
during female ES cell differentiation. a, immunostaining of Ring1b
(red) and ubH2A (green) in nuclei (blue) of undifferentiated female ES
cells. b and c, after 3 days of differentiation, female ES cells were
stained with anti-H3–3mK27 (green) and anti-Ring1b (red) or anti-
ubH2A (red) antibodies as indicated. The merged images show that
Ring1b and ubH2A colocalize and are enriched on the Xi. d, quantifi-
cation of the immunostaining patterns during ES cell differentiation.
The graphs depict the percentage of cells with Xi accumulation for Ezh2
(open circles), H3–3mK27 (solid circles), Ring1b (open squares), and
ubH2A (solid squares), respectively. More than 100 cells were counted
after 2, 3, 4, 7, 10, and 13 days of differentiation.
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protein was found to be enriched on the Xi at any stage of ES
cell differentiation (supplemental Fig. S3) suggesting that the
Ring1b complex involved in X inactivation is likely different
from that of the one purified from HeLa cells (16). Collectively,
the above results also suggest that Ring1b-mediated H2A ubiq-
uitination is involved in the initiation stage of X inactivation,
since its enrichment on the Xi correlates with initiation of X
inactivation.
Since the discovery of the Xist RNA (35, 36), a great deal of
effort in the study of X inactivation has focused on identifica-
tion of Xist RNA associated factors and characterization of
Xi-linked epigenetic modifications (20). These efforts have re-
sulted in identification of a number of Xi-linked chromatin
features including histone hypoacetylation (37), H3-K9 (38–
41), and H3-K27 (23, 24) methylation and incorporation of a
variant H2A, macroH2A (42). In addition, Polycomb group
proteins involved in H3-K27 methylation were also identified
to associate with Xi in an Xist RNA-dependent manner (23, 24).
The present study demonstrates that ubiquitinated H2A and
its corresponding ligase Ring1b are epigenetic features of the
Xi. Their dynamic association with Xi in TS and ES cells
suggest a role in the initiation stage of both imprinted and
random X inactivation.
The PcG of proteins were initially identified in Drosophila
during genetic screens to identify factors involved in heritable
silencing of homeobox genes and have since been found to be an
evolutionarily conserved gene silencing system (43, 44). PcG
proteins function in at least two distinctive protein complexes
including the Eed-Ezh2 complex and the PRC1 complex (21,
22). The fact that the Eed-Ezh2 complex and its associated
H3-K27 methyltransferase activity are recruited to Xi and par-
ticipate in X inactivation (23–25), in combination with the fact
that the two PcG complexes can function together to mediate
Hox gene silencing, prompted us to investigate a possible role
of Ring1b-mediated H2A ubiquitination in X inactivation. We
demonstrated that, similar to Ezh2 and its associated H3-K27
methyltransferase activity, Ring1b and its associated H2A
ubiquitination ligase activity are enriched in Xi and are mitot-
ically stable in TS cells (Figs. 1 and 2). Interestingly, the
enrichment of Ring1b and ubH2A on Xi does not persist during
TS cell differentiation suggesting that it may not be required
for maintenance of imprinted X inactivation during TS cell
differentiation (Fig. 3). We also demonstrate that enrichment
of Ring1b and ubH2A on Xi correlates with initiation of X
inactivation during ES cell differentiation. Thus, our results
identify a new epigenetic marker for Xi and link H2A ubiquiti-
nation to initiation of X inactivation. This study, coupled with
our previous demonstration of the involvement of the Eed-Ezh2
complex in X inactivation (23), suggest that similar to Hox gene
silencing, X inactivation may also involve coordinated action of
the two PcG complexes and their associated enzymatic activi-
ties. Further studies should reveal the exact mechanism by
which H2A ubiquitination participates in X inactivation.
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